Natural Product: NPC181709

Natural Product IDNPC181709
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Methyl P-Hydroxycinnamyl Ketone
IUPAC Name (E)-4-(4-hydroxyphenyl)but-3-en-2-one
Synonyms Methyl P-Hydroxycinnamyl Ketone
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL9184
PubChem CID 796857
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000476] Cinnamic acids and derivatives
        • [CHEMONTID:0001391] Hydroxycinnamic acids and derivatives

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey OCNIKEFATSKIBE-NSCUHMNNSA-N
Standard InCHI InChI=1S/C10H10O2/c1-8(11)2-3-9-4-6-10(12)7-5-9/h2-7,12H,1H3/b3-2+
SMILES CC(=O)/C=C/c1ccc(cc1)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   162.07 Volume:   177.358
?
Van der Waals volume.
Dense:   0.914 LogP:   2.018
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   2.075
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -2.432
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   2.0 Rigid Bonds:   8.0
TPSA:   37.3
?
Topological Polar Surface Area.
H-Bond Acceptor:   2.0
H-Bond Donor:   1.0 Rings:   1.0
Heavy Atoms:   2.0

MedChem Properties

QED Drug-Likeness Score:   0.675 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   1.914 Fsp3:   0.1
MCE-18:   6.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Rejected
Golden Triangle Rule:   Accepted BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.419 Fluc inhibitor:   1.0
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.019
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.185
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.999 Promiscuous compounds:   0.435

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -4.706 MDCK Permeability:   -4.78
Pgp-inhibitor:   0.362 Pgp-substrate:   0.075
PAMPA:   0.332
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.013
20% Bioavailability (F20%):   0.84 30% Bioavailability (F30%):   0.78
50% Bioavailability (F50%):   0.984

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.016 MRP1:   0.297
Plasma Protein Binding (PPB):   79.588% Volume Distribution (VD):   -0.215
Fu: 19.104%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.978
OATP1B3 inhibitor:   0.983 BCRP inhibitor:   0.221
BSEP inhibitor:   0.931

ADMET: Metabolism

CYP1A2-inhibitor:   0.141 CYP1A2-substrate:   0.71
CYP2C19-inhibitor:   0.017 CYP2C19-substrate:   0.187
CYP2C9-inhibitor:   0.104 CYP2C9-substrate:   0.463
CYP2D6-inhibitor:   0.958 CYP2D6-substrate:   0.081
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.987
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   1.0
HLM stability:   0.116
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  11.502 Half-life (T1/2):  1.01

ADMET: Toxicity

hERG Blockers:  0.221 hERG Blockers (10um):  0.497
Human Hepatotoxicity (H-HT):  0.791 Drug-induced Liver Injury (DILI):  0.218
AMES Toxicity:  0.492 Rat Oral Acute Toxicity:  0.077
Maximum Recommended Daily Dose:  0.31 Skin Sensitization:  0.944
Carcinogencity:  0.264 Eye Corrosion:  0.87
Eye Irritation:  0.997 Respiratory Toxicity:  0.497
Drug-induced Neurotoxicity:  0.802 Ototoxicity:  0.157
Hematotoxicity:  0.106 Drug-induced Nephrotoxicity:  0.193
Genotoxicity:  0.444 RPMI-8226 Immunitoxicity:  0.049
A549 Cytotoxicity:  0.112 Hek293 Cytotoxicity:  0.207
BCF:   1.055
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.622
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.696
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.438
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO19774 Rubus idaeus Species n.a. n.a. n.a. n.a. n.a. PMID[ 10835233]
NPO19774 Rubus idaeus Species n.a. n.a. Fruit n.a. n.a. DOI[10.1016/S0963-9969(99)00095-2]
NPO6836 Alpinia blepharocalyx Species Zingiberaceae Eukaryota seeds Mengha, Yunnan Province, China 1991-Aug PMID[11277741]
NPO6836 Alpinia blepharocalyx Species Zingiberaceae Eukaryota seeds n.a. n.a. PMID[11325233]
NPO6836 Alpinia blepharocalyx Species Zingiberaceae Eukaryota Seeds n.a. n.a. PMID[11430002]
NPO19774 Rubus idaeus Species n.a. n.a. n.a. n.a. n.a. PMID[21381697]
NPO19774 Rubus idaeus Species n.a. n.a. n.a. n.a. n.a. PMID[37570937]
NPO6836 Alpinia blepharocalyx Species Zingiberaceae Eukaryota n.a. n.a. n.a. PMID[9461664]
NPO6836 Alpinia blepharocalyx Species Zingiberaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO19774 Rubus idaeus Species n.a. n.a. n.a. n.a. n.a. Database[COCONUT]
NPO19774 Rubus idaeus Species n.a. n.a. Leaf n.a. n.a. Database[FooDB]
NPO19774 Rubus idaeus Species n.a. n.a. Fruits n.a. Database[FooDB]
NPO19774 Rubus idaeus Species n.a. n.a. n.a. n.a. Database[FooDB]
NPO19774 Rubus idaeus Species n.a. n.a. Seed n.a. n.a. Database[FooDB]
NPO19774 Rubus idaeus Species n.a. n.a. Fruit n.a. n.a. Database[FooDB]
NPO6836 Alpinia blepharocalyx Species Zingiberaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO19774 Rubus idaeus Species n.a. n.a. n.a. n.a. n.a. Database[HerDing]
NPO19774 Rubus idaeus Species n.a. n.a. Fruits n.a. Database[Phenol-Explorer]
NPO19774 Rubus idaeus Species n.a. n.a. n.a. n.a. Database[Phenol-Explorer]
NPO6836 Alpinia blepharocalyx Species Zingiberaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO19774 Rubus idaeus Species n.a. n.a. n.a. n.a. n.a. Database[TCMID]
NPO6836 Alpinia blepharocalyx Species Zingiberaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO19774 Rubus idaeus Species n.a. n.a. n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT111 Cell line K562 Homo sapiens IC50 = 60000.0 nM DOI[10.1016/S0960-894X(97)10147-0]
NPT453 Cell line HT-1080 Homo sapiens ED50 > 100.0 uM PMID[11277741]
NPT804 Cell line HT-22 Mus musculus Activity = 50.0 % PMID[25313922]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. ED50 > 100.0 uM PMID[11277741]
NPT21334 Cell line MC3T3-E1 Mus musculus Activity = 110.0 % PMID[31257875]
NPT21334 Cell line MC3T3-E1 Mus musculus Activity = 150.0 % PMID[31257875]
NPT19 Organism Escherichia coli Escherichia coli IC50 = 1202264.43 nM PMID[12161116]
NPT419 Organism Oryctolagus cuniculus Oryctolagus cuniculus IC50 = 1803017740859.57 nM PMID[15911266]
NPT419 Organism Oryctolagus cuniculus Oryctolagus cuniculus IC50 = 66069.34 nM PMID[15911266]
NPT2 Others Unspecified n.a. Ratio IC50 > 5.0 n.a. PMID[21500839]
NPT2 Others Unspecified n.a. IC50 > 50000.0 nM PMID[21500839]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC181709 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.7419 Intermediate Similarity NPC68269
0.7097 Intermediate Similarity NPC79672
0.6786 Remote Similarity NPC248817
0.6452 Remote Similarity NPC286006
0.6389 Remote Similarity NPC201967
0.6389 Remote Similarity NPC51698
0.6053 Remote Similarity NPC130193
0.6 Remote Similarity NPC311343
0.5833 Remote Similarity NPC171843
0.5806 Remote Similarity NPC239808
0.5714 Remote Similarity NPC253746
0.5714 Remote Similarity NPC17525
0.5676 Remote Similarity NPC304638
0.5625 Remote Similarity NPC104216
0.561 Remote Similarity NPC14007
0.5588 Remote Similarity NPC184169
0.5476 Remote Similarity NPC71941
0.5476 Remote Similarity NPC88141
0.5294 Remote Similarity NPC175298
0.525 Remote Similarity NPC116842
0.5238 Remote Similarity NPC472585
0.5227 Remote Similarity NPC285350
0.5172 Remote Similarity NPC265146
0.5128 Remote Similarity NPC19174
0.5128 Remote Similarity NPC73532
0.5128 Remote Similarity NPC115159

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC181709 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data